Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

11.1%

2 terminated/withdrawn out of 18 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

11%

2 trials in Phase 3/4

Results Transparency

117%

14 of 12 completed trials have results

Key Signals

4 recruiting14 with results

Enrollment Performance

Analytics

N/A

12(75.0%)

Phase 2

2(12.5%)

Phase 4

2(12.5%)

16Total

N/A(12)

Phase 2(2)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials

NCT07222150Not ApplicableRecruiting

Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness

Role: collaborator

NCT06865144Phase 4Recruiting

Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT

Role: collaborator

NCT06953349Recruiting

Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis

Role: collaborator

NCT06933836Recruiting

DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma

Role: collaborator

NCT02763124Not ApplicableCompleted

Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate Incisions

Role: collaborator

NCT02987660Not ApplicableTerminated

Comparison of Topography Guided LASIK With WaveLight® EX500 to SMILE With Zeiss VisuMax

Role: lead

NCT02974140Not ApplicableTerminated

Cataract Refractive Suite Study

Role: lead

NCT03026257Not ApplicableCompleted

Clinical Assessment of a HYDRAGLYDE® Regimen

Role: lead

NCT02965820Not ApplicableCompleted

OPTI-FREE® PureMoist® for Presbyopic Contact Lens Wearers

Role: lead

NCT02965833Not ApplicableCompleted

CLEAR CARE® PLUS for Presbyopic Contact Lens Wearers

Role: lead

NCT02939170Not ApplicableCompleted

Initial Performance of a Daily Disposable Contact Lens Featuring Molded Marks

Role: lead

NCT02750813Not ApplicableCompleted

ACUVUE® OASYS® 1-DAY vs DAILIES TOTAL1®

Role: lead

NCT02355028Phase 2Completed

LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular Degeneration

Role: lead

NCT02871375Not ApplicableCompleted

Clinical Assessment of DAILIES TOTAL1® (DT1) Multifocal

Role: lead

NCT02365519Phase 2Completed

LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye Disease

Role: lead

NCT02403206Not ApplicableCompleted

Femtosecond Laser Assisted Cataract Surgery in Intumescent Cataracts

Role: lead

NCT02450799Not ApplicableCompleted

Corrected VA With Long-Term Follow-Up After AcrySof® Intraocular Lens (IOL) Implantation

Role: lead

NCT02325518Phase 4Completed

Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution

Role: lead

All 18 trials loaded